{"id":"W4321764716","doi":"10.1182/bloodadvances.2022009138","title":"Impact of second primary malignancy post–autologous transplantation on outcomes of multiple myeloma: a CIBMTR analysis","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University","funders":"Cancer Moonshot; National Institute of Allergy and Infectious Diseases; Office of Naval Research; Legend Biotech; Pharmacyclics; Takeda Oncology; U.S. Navy; Health Resources and Services Administration; National Institutes of Health; MorphoSys; Astellas Pharma; Adaptive Biotechnologies; Pfizer; Incyte; Kiadis Pharma; bluebird bio; TG Therapeutics; Medac; Jazz Pharmaceuticals; Swedish Orphan Biovitrum; Omeros Corporation; Vertex Pharmaceuticals; StemCyte; National Center for Advancing Translational Sciences; HistoGenetics; U.S. Department of Defense; Moonshot Research and Development Program; Sanofi; GlaxoSmithKline; Actinium Pharmaceuticals; CareDx; National Heart, Lung, and Blood Institute; Novartis Pharmaceuticals Corporation; CSL Behring; Bristol-Myers Squibb; AstraZeneca; Amgen; Mallinckrodt Pharmaceuticals; Astellas Pharma US; Atara Biotherapeutics; National Cancer Institute; Gilead Sciences","keywords":"Multiple myeloma; Medicine; Malignancy; Transplantation; Oncology; Bone transplantation; Internal medicine; Surgery","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005319156,0.0003705198,0.0006221181,0.001467538,0.0002367239,0.0009091777,0.0007907753,0.0003720823,0.001956163],"category_scores_gemma":[0.005575794,0.0001701826,0.001997805,0.001749123,0.0002749284,0.0006403481,0.001163889,0.0009793843,0.000218136],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006340732,"about_ca_system_score_gemma":0.000675914,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002907947,"about_ca_topic_score_gemma":0.003694132,"domain_scores_codex":[0.9980526,0.0006496374,0.0001798982,0.0004103521,0.0004639983,0.0002435176],"domain_scores_gemma":[0.9945796,0.001366405,0.002371543,0.0006643521,0.0004450005,0.0005733013],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001165091,0.00004012587,0.9923882,0.00004419999,0.0006202961,0.00005679631,0.00003222451,0.000440235,0.0001567266,0.0000489065,0.0002155452,0.004791595],"study_design_scores_gemma":[0.00003494676,0.0002996932,0.9975461,0.00001374304,0.0005042774,0.000187594,0.00004762228,0.00091002,0.00007764577,0.00003450982,0.0003361523,0.0000077532],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9964043,0.001085371,0.000235455,0.00008208227,0.000009927651,0.00002166928,0.001334235,0.00000985152,0.0008170396],"genre_scores_gemma":[0.9984307,0.0001695259,0.00009799261,0.00003660383,0.00001929742,0.00001588389,0.001146681,0.000006099533,0.00007720086],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005319156,"threshold_uncertainty_score":0.02813077,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01742792174734513,"score_gpt":0.3275683512550087,"score_spread":0.3101404295076635,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}